20537 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having three or more nucleosides or nucleotides Double-stranded nucleic acids or oligonucleotides
COMBINATION CANCER THERAPY WITH C-MET INHIBITORS AND SYNTHETIC OLIGONUCLEOTIDES
#3002Pappalysin Regulator
#3003Nucleic acid particles, methods and use thereof
#3004AMPHOTERIC LIPOSOME FORMULATIONS
#3005NANOCARRIER SYSTEM FOR MICRORNAS AND USES THEREOF
#3006Compositions and methods for inhibiting expression of TMPRSS6 gene
#3007Dnazyme for silencing the expression of EGFR
#3008LIVER CANCER RELATED GENES-SPECIFIC siRNA, DOUBLE-STRANDED OLIGO RNA MOLECULES COMPRISING THE siRNA, AND COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING THE SAME
#3009METHOD FOR THE TARGETED KILLING OF CELLS BY NUCLEOTIDE MOLECULES THAT ARE DIRECTED TO mRNA BINDING, AND ALSO NUCLEOTIDE MOLECULES AND APPLICATION KIT FOR SUCH USE
#3010RNAi agent for inhibition of Chikungunya virus
#3011MULTIVALENT APTAMER COMPLEXES
#3012Albumin production and cell proliferation
#3013AGONISTS OF DDAH1 FOR TREATING ENDOTHELIAL DYSFUNCTION
#3014Compositions and methods for the delivery of nucleic acids
#3015Micro-RNA family that modulates fibrosis and uses thereof
#3016Micro-RNA family that modulates fibrosis and uses thereof
#3017Micro-RNA family that modulates fibrosis and uses thereof
#3018Methods for expressing a polynucleotide of interest in the retina of a subject
#3019Method of treating intracellular infection
#3020Compositions, kits and methods for treatment of cardiovascular,immunological and inflammatory diseases
#3021Methods and compositions for modulating cancer stem cells
#3022Glucan-encapsulated siRNA for treating type 2 diabetes mellitus
#3023Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
#3024Cationic lipids for therapeutic agent delivery formulations
#3025Targeting ABCB5 for cancer therapy
#3026Use of immobilization particles for removal of microorganisms and/or chemicals
#3027Use of HMGA-targeted phosphorothioate DNA aptamers to suppress carcinogenic activity and increase sensitivity to chemotherapy agents in human cancer cells
#3028Detection and treatment of autoimmune disorders
#3029Agents for improved delivery of nucleic acids to eukaryotic cells
#3030Preventive or therapeutic agent for fibrosis
#3031Double-stranded antisense nucleic acid with exon-skipping effect
#3032ANTI-CXCL9, ANTI-CXCL10, ANTI-CXCL11, ANTI-CXCL13, ANTI-CXCR3 AND ANTI-CXCR5 AGENTS FOR INHIBITION OF INFLAMMATION
#3033COMBINATION THERAPY
#3034Method for Inhibiting HIV Replication in Mammal and Human Cells
#3035Treatment of hyperhidrosis
#3036COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES
#3037COMPOSITIONS AND METHODS FOR DETECTING AND TREATING GLIOBLASTOMA
#3038Methods for identifying agents useful for modulating the expression and aggregation of CAG-expanded gene product in cells
#3039Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFLD)
#3040RNA interference in ocular indications
#3041Compositions and methods for inhibiting expression of the ALAS1 gene
#3042RNAi vitamin D conjugates
#3043MODULATORS OF ADP-DEPENDENT GLUCOKINASE (ADPGK) AND GLYCEROL-3-PHOSPHATE DEHYDROGENASE (GPD2) FOR THERAPY
#3044Hydrophobically modified antisense oligonucleotides comprising a triple alkyl chain
#3045Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
#3046Method for inhibiting HIV replication in mammal and human cells
#3047Complement component C5 iRNA compositions and methods of use thereof
#3048Modulation of HSP47 expression
#3049Hydrophobically modified antisense oligonucleotides comprising a ketal group
#3050Targeting microRNAs for the treatment of fibrosis
#3051Inflammatory disease diagnosis and methods of treatment using lipopolysaccharides-responsive beige-like anchor
#3052Therapeutics for the induction of endogenous steroidogenesis and methods associated with their identification
#3053Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptides
#3054Targeted therapeutic nanoparticles
#3055Lipids and lipid compositions for the delivery of active agents
#3056CFTR mRNA compositions and related methods and uses
#3057AMPHIPHILIC BLOCK COPOLYMERS FOR NUCLEIC ACID DELIVERY
#3058Protection against ionizing radiation and chemotherapy toxicity via latexin regulation
#3059Oligonucleotide analogues targeting human LMNA
#3060Monomers and oligonucleotides comprising cycloaddition adduct(s)
#3061Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#3062PROMOTION OF WOUND HEALING
#3063Amino lipids and methods for the delivery of nucleic acids
#3064SDF-1 binding nucleic acids and the use thereof in cancer treatment
#3065Antisense compounds and uses thereof
#3066Methods to prevent and treat autosomal dominant non-syndromic hearing loss
#3067Compositions and methods for modulating apolipoprotein (a) expression
#3068Compositions and methods for modulating apolipoprotein C-III expression
#3069Composition and method for inner ear sensory hair cell regeneration and replacement
#3070Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#3071Molecular Targets for Cardiovascular Disease
#3072Use of MicroRNA or inhibitors thereof in regulation of lipid metabolism
#3073Synthetic lethality in cancer
#3074Phase changing formulations of nucleic acid payloads
#3075Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells
#3076Molecular targets for ALS and related disorders
#3077Nano-plasmonic molecular probes and methods of use
#3078RNA aptamers against BAFF-R as cell-type specific delivery agents and methods for their use
#3079Compositions and methods for silencing marburg virus gene expression
#3080RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)
#3081Compositions and methods
#3082Compositions and methods for modulating HBV expression
#3083siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
#3084Nanoparticles for drug delivery comprising albumin having a polymer chain coupled thereto
#3085Peptide-mediated intravesical delivery of therapeutic and diagnostic agents
#3086COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
#3087Hydrazinyl lipidoids and uses thereof
#3088Compositions and methods for “resistance-proof” SiRNA therapeutics for influenza
#3089miR-29 mimics and uses thereof
#3090COMPOSITIONS AND METHODS FOR INHIBITING CHEMORESISTANCE IN CANCER AND IMPROVING RESPONSE TO THERAPY
#3091Hydrazinyl lipidoids and uses thereof
#3092Composition comprising inhibitor against PAPSS2 gene or protein encoded by gene for inducing senescence in tumor cells and method for inducing senescence in tumor cells using the same
#3093Synthetic mimics of miR-124
#3094Targeting trastuzumab-resistant HER2+ breast cancer with a HER3-targeting nanoparticle
#3095Methods for cancer treatment
#3096Lipopeptides for delivery of nucleic acids
#3097Anti-tumor compositions and methods
#3098Methods for treating hair loss disorders
#3099Methods for treating hair loss disorders
#3100Particulate pharmaceutical composition
#3101Genetic amplification of IQGAP1 in cancer
#3102SYNTHETIC MIMICS OF MIR-34
#3103Method for assaying microRNA, cancer therapeutic agent, and medicinal composition containing same for cancer therapy
#3104Bruton's tyrosine kinase as anti-cancer drug target
#3105Usage of mycophenolate mofetil or salt thereof in preparing drug for resisting against influenza virus
#3106Carbohydrate conjugates as delivery agents for oligonucleotides
#3107Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
#3108METHODS AND PHARMACEUTICAL COMPOSITIONS (CTPS 1 INHIBITORS, E.G. NORLEUCINE) FOR INHIBITING T CELL PROLIFERATION IN A SUBJECT IN NEED THEREOF
#3109DRUG CARRIER HAVING SELF-ASSEMBLED 3-D NUCLEIC ACID NANOSTRUCTURE
#3110Transcriptome transfer produces cellular phenotype conversion
#3111Targeting chromatin modifiers for the treatment of medical conditions
#3112Interferon production using short RNA duplexes
#3113Methods for modulating chemotherapeutic cytotoxicity
#3114UREIDO-PYRAZOLE DERIVATIVES
#3115Biological Materials and Uses Thereof
#3116DRUG CARRIER AND DRUG CARRIER KIT FOR INHIBITING FIBROSIS
#3117Treatment of myocardial infarction by inhibiting the action of mAKAPβ
#3118Rapidly Adaptable Nano Therapeutics for Treatment of Infectious Disease
#3119Methods of treating renal disease and other disorders
#3120Encapsulation of messenger RNA
#3121NANOPARTICLE FABRICATION METHODS, SYSTEMS, AND MATERIALS
#3122Method of enhancing delivery of therapeutic compounds to the eye
#3123Non-liposomal systems for nucleic acid delivery
#3124Inhibitors of MYH7B and uses thereof
#3125ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
#3126Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
#3127Methods for Promoting Reinnervation of Auditory Hair Cells
#3128Treatment of staphylococcal disorders
#3129Vectors for delivery of agents across biological membranes
#3130Therapeutic agent for fibroid lung
#3131Biomarker Hsp90 for predicting effect of a c-Met inhibitor
#3132Methods of Manipulating the Fate of Cells
#3133Cholestosome vesicles for incorporation of molecules into chylomicrons
#3134METHODS OF DIAGNOSING AND TREATING FIBROSIS
#3135Methods and compositions related to T-cell activity
#3136Sequence specific antimicrobials
#3137Treatment of LCAT gene related diseases by inhibition of a natural antisense transcript to LCAT
#3138Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
#3139Methods for including cardiomyocyte proliferation
#3140Method and composition for hyperthermally treating cells
#3141Biodegradable poly (beta-amino esters) and uses thereof
#3142Medicament for liver regeneration and for treatment of liver failure
#3143Lipid nanoparticles for transfection and related methods
#3144MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT
#3145PCSK9 iRNA compositions and methods of use thereof
#3146Method for expressing, secreting and transferring functional microRNAs/siRNAs and application thereof
#3147Selective targeting of cancer stem cells
#3148TIM RECEPTORS AS VIRUS ENTRY COFACTORS
#3149Methods and compositions for modulating Tau levels
#3150Oligomers and oligomer conjugates
#3151Treatment of tristetraproline (TTP) related diseases by inhibition of natural antisense transcript to TTP
#3152Locked nucleic acid inhibitor of miR-145 and uses thereof
#3153Organic compositions to treat EPAS1-related diseases
#3154Method for treating and/or preventing myopia
#3155Methods of preserving and protecting pancreatic beta cells and treating or preventing diabetes by inhibiting NOX-1
#3156Biodegradable lipids for the delivery of active agents
#3157Method of altering vascular permeability and uses thereof
#3158Methods and Compositions for the Prevention and Treatment of Parasitic Disease
#3159Methods of treating cancer
#3160Tetrary gene delivery system for gene therapy and methods of its use
#3161Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents
#3162Screening method, a kit, a method of treatment and a compound for use in a method of treatment
#3163Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability
#3164Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1
#3165RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
#3166METHODS AND COMPOSITIONS FOR MANAGING VASCULAR CONDITIONS
#3167Notch inhibition in the prevention of vein graft failure
#3168Nanoparticles stabilized with nitrophenylboronic acid compositions
#3169Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone-associated medical conditions
#3170Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes
#3171Oligonucleotide
#3172Composition for gene delivery comprising chitosan and liquid crystal formation material
#3173NOVEL PH -SWITCHABLE PEPTIDES FOR MEMBRANE INSERTION AND PORE FORMATION
#3174Lipid formulations for delivery of therapeutic agents to solid tumors
#3175COMPOSITIONS AND METHODS FOR REGULATING CELL GROWTH AND DEVELOPMENT
#3176COMPOSITIONS AND METHODS OF INHIBITING GENE EXPRESSION IN A LUNG
#3177Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features
#3178Compositions and methods for treating pancreatic cancer
#3179LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES
#3180Anti-IL-6 antibodies for the treatment of oral mucositis
#3181Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with P75
#3182Antibody-drug conjugates and uses thereof
#3183Intranuclear protein transduction through a nucleoside salvage pathway
#31842′-methoxy substituted oligomeric compounds and compositions for use in gene modulations
#3185Method of treating obesity
#3186METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#3187Cancer antigen EEF2
#3188Lipids, lipid complexes and use thereof
#3189EXTENDED-RELEASE DRUG DELIVERY COMPOSITIONS
#3190Aptamer against midkine and applications thereof
#3191Use of human biliverdin reductase and fragments thereof for the treatment of protein kinase C-delta and ERK related conditions
#3192SUBSTANCES AND METHODS FOR THE TREATMENT OF CEREBRAL AMYLOID ANGIOPATHY RELATED CONDITIONS OR DISEASES
#3193STABILIZED STAT3 DECOY OLIGONUCLEOTIDES AND USES THEREFORE
#3194Plants as functional microRNA and/or functional siRNA carriers, preparation methods and uses thereof
#3195METHOD FOR INCREASING NEPRILYSIN EXPRESSION AND ACTIVITY
#3196Polyvalent RNA-nanoparticle compositions
#3197Methods and compositions involving miRNA and miRNA inhibitor molecules
#3198Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias
#3199Methods and compositions involving miRNA and miRNA inhibitor molecules
#3200Methods of trans-differentiating a terminally differentiated target cell to a neuron
#3201Sonochemical induction of ABCA1 expression and compositions therefor
#3202Targeted sensitization of non-del(5q) malignant cells
#3203BIOMARKERS FOR CHRONIC TRAUMATIC ENCEPHALOPATHY
#3204dsRNA For Treating Viral Infection
#3205COMPOSITIONS AND METHODS TARGETING SIGNALING BY THE G PROTEIN BETA-GAMMA SUBUNIT FOR THE TREATMENT OF ASTHMA
#3206Methods and compositions for the production of siRNAs
#3207Recombinant adenovirus with increased safety and anticancer activities, and use thereof
#3208Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers
#3209LDH inhibitors as treatment for fibrosis and fibrotic-related disorders
#3210Viral immunogenic compositions
#3211Apoptosis-inducing agent
#3212Method of preparing composition for delivering an anionic drug
#3213Systems and methods for diagnosing and treating cancer
#3214SATB1: A DETERMINANT OF MORPHOGENESIS AND TUMOR METASTATIS
#3215Compositions and methods for diagnosis, prognosis and treatment of hematological malignancies
#3216Formulations for treating amyloidosis
#3217Methods and compositions of improved modified siRNA
#3218Cancer treatment and immune system regulation through FAT10 pathway inhibition
#3219Manipulation of hairy and enhancer of split 3 (Hes3) and its regulators/mediators as an anti-cancer strategy
#3220Inhibition of cancer growth and metastasis
#3221Compounds suited as nanocarriers for active agents and their use
#3222Methods used to characterize and treat glioblastoma
#3223Methods For Bone Treatment By Modulating An Arachidonic Acid Metabolic or Signaling Pathway
#3224NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
#3225Methods of inhibiting cancer stem cells with HMGA1 inhibitors
#3226Compositions and methods for silencing apolipoprotein C-III expression
#3227Method for inhibiting calcification of a macrophage-derived matrix vesicle
#3228Compositions and methods for selective delivery of oligonucleotide molecules to cell types
#3229Compositions and methods for polynucleotide transfection
#3230Amphipathic peptide
#3231SIRNA AGAINST CBL-B AND OPTIONALLY IL-2 AND IL-12 FOR USE IN THE TREATMENT OF CANCER
#3232Methods of improving RNAi in well-differentiated airway epithelia
#3233Use of TRMP8 for treating opthalmic diseases or conditions involving tearing
#3234FGFR3 fusion gene and pharmaceutical drug targeting same
#3235Multiple targeted RNAI for the treatment of cancers
#3236Double-stranded ribonucleic acid for adjuvants
#3237UNA OLIGOMERS HAVING REDUCED OFF-TARGET EFFECTS IN GENE SILENCING
#3238Transthyretin allele selective UNA oligomers for gene silencing
#3239METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BONE METASTASES
#3240Antibody-SN-38 immunoconjugates with a CL2A linker
#3241Tumor-Specific Delivery of Therapeutic Agents via Liposomase/US
#3242miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers
#3243Nucleic acid lipid particle formulations
#3244Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer
#3245Competitive modulation of microRNAs
#3246Inkjet gene printing
#3247Composition for treating cancer associated with HPV infection
#3248Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
#3249Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
#3250MICROMIRs
#3251METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES
#3252Compositions and methods for inhibiting hypdxia induced damage
#3253Methods for treating parkinson's disease by optically stimulating target cells
#3254Compositions and methods for inhibiting viral entry
#3255METHODS FOR THE TREATMENT AND DIAGNOSIS OF ATHEROSCLEROSIS
#3256Methods and Compositions for treatment of cancer by inhibition of NR2F2
#3257Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway
#3258In Vivo Delivery of Nucleic Acids to the Liver or Liver Tissue
#3259Methods for treating renal disease
#3260Compositions to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
#3261Sortilin 1 is a novel inducer of vascular calcification
#3262Extraction, preparation, and application of plant micro-ribonucleic acid
#3263Organic compositions to treat beta-catenin-related diseases
#3264Short interference RNA gene delivery system for systemic circulation
#3265Methods of treating kennedy's disease
#3266PME-1 as a biomarker to predict and diagnose endometrial and breast cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition
#3267Organic compositions to treat HSF1-related diseases
#3268Diffusible factors and cancer cells
#3269METHODS FOR MODULATING IMMUNE RESPONSES DURING CHRONIC IMMUNE CONDITIONS BY TARGETING IL-27 INDUCED PATHWAYS
#3270Methods to regulate polarization and enhance function of cells
#3271Treatment of Myelodysplastic Syndrome by Inhibition of NR2F2
#3272Combination therapies for the treatment of Alzheimer's disease and related disorders
#3273Organic compositions to treat beta-ENaC-related diseases
#3274Methods and compositions for inhibition of immune responses and autoimmunity
#3275Delivery of dsRNA to arthropods
#3276Antisense antiviral compounds and methods for treating a filovirus infection
#3277Triazine cationic polymers and methods of use thereof
#3278Bioreducible Poly (Beta-Amino Ester)s For siRNA Delivery
#3279Biodegradable lipids for the delivery of active agents
#3280Layer-By-Layer Approach to Co-Deliver DNA and siRNA via AuNPs: A Potential Platform for Modifying Release Kinetics
#3281Blood clotting control
#3282Lipidosome preparation, preparation method and application thereof
#3283POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY INCLUDING TRANSDERMAL DELIVERY OF CARGO AND METHODS THEREOF
#3284Therapies based on control of regulatory T cell stability and function via a neuropilin-1:semaphorin axis
#3285DETECTION AND TREATMENT OF NON-DERMAL FIBROSIS
#3286MODULATION OF MUC1 ACTIVITY
#3287Method and composition for hyperthermally treating cells
#3288SYSTEMS AND METHODS OF DELIVERY OF BIOACTIVE AGENTS USING BACTERIAL TOXIN-DERIVED TRANSPORT SEQUENCES
#3289SYSTEMS AND METHODS OF DELIVERY OF BIOACTIVE AGENTS USING BACTERIAL TOXIN-DERIVED TRANSPORT SEQUENCES
#3290Lipids and compositions for the delivery of therapeutics
#3291Cancer marker and utilization thereof
#3292AMPHIREGULIN-SPECIFIC DOUBLE-HELICAL OLIGO-RNA, DOUBLE-HELICAL OLIGO-RNA STRUCTURE COMPRISING DOUBLE-HELICAL OLIGO-RNA, AND COMPOSITION FOR PREVENTING OR TREATING RESPIRATORY DISEASES CONTAINING SAME
#3293Gene silencing methods
#3294CLUSTER OF DIFFERENTIATION 36 (CD36) AS A THERAPEUTIC TARGET FOR HIV INFECTION
#3295Methods and Pharmaceutical Compositions for Treatment of Gastrointestinal Stromal Tumors
#3296Nanotubes as carriers of nucleic acids into cells
#3297Method of treating cancer
#3298Rapid formation of chitosan sponges using guanosine 5′-diphosphate: injectable scaffolds for tissue regeneration and drug delivery
#3299NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
#3300Compositions and methods for promoting intestinal stem cell function